29 results
PRER14A
GLSHQ
Gelesis Holdings, Inc.
7 Sep 23
Preliminary revised proxy
4:03pm
or extend any labor agreement, other than as required by applicable law, or recognize or certify any labor union, labor organization, or group of employees …
In the European Union medical devices were previously regulated under Directive 93/42/EEC, also known as the Medical Device Directive (“MDD
PREM14A
GLSHQ
Gelesis Holdings, Inc.
24 Jul 23
Preliminary proxy related to merger
9:47pm
or certify any labor union, labor organization, or group of employees of the Company or its subsidiaries as the bargaining representative for any … Considerations for Outside the United States
In the European Union medical devices were previously regulated under Directive 93/42/EEC, also known
8-K
EX-2.1
GLSHQ
Gelesis Holdings, Inc.
13 Jun 23
Entry into a Material Definitive Agreement
7:29am
of Control Payment;
(xii) any collective bargaining agreements and any other agreements executed with a union or similar organization;
(xiii) any … Subsidiaries, (iii) no employees of the Company or any of its Subsidiaries are or have been represented by any labor union or other employee
424B3
GLSHQ
Gelesis Holdings, Inc.
16 Nov 22
Prospectus supplement
4:51pm
in the European Union. Plenity also competes with injectable pharmaceutical obesity therapies, including Saxenda and Wegovy marketed by Novo Nordisk … to as the Hatch-Waxman Amendments, and similar legislation in the European Union. The Hatch-Waxman Amendments permit a patent term extension of up
424B3
fkg5qpmq7lw8lujj3949
16 Nov 22
Prospectus supplement
4:48pm
424B3
313sg
16 Sep 22
Prospectus supplement
11:19am
424B3
1chd99c3
6 Sep 22
Prospectus supplement
4:53pm
8-K
EX-10.1
vcatmg4l
12 Aug 22
Entry into a Material Definitive Agreement
4:02pm
424B3
2g4ap36hv lus
8 Jun 22
Prospectus supplement
4:21pm
424B3
ich epma4
27 Dec 21
Prospectus supplement
12:00am